Unknown

Dataset Information

Novel approach to alleviate lupus nephritis: targeting the NLRP3 inflammasome in CD8<sup>+</sup>CD69<sup>+</sup>CD103<sup>+</sup> T<sub>RM</sub> cells.


ABSTRACT:

Background

Renal CD8+ tissue-resident memory T (TRM) cells display prolonged survival and activity in lupus nephritis (LN), exacerbating renal pathology. NLRP3 regulates the T cell response. This study explored the impact of NLRP3 inflammasome activity on the regulatory functions of TRM cells in LN.

Methods

NLRP3 inflammasome activity in renal CD8+ TRM cells from lupus-prone MRL/lpr mice and in vitro induced human CD8+CD103+ T cells was assessed by quantifying NLRP3, caspase-1, gasdermin D (GSDMD), and IL-1β levels using flow cytometry, ELISA, and western blotting analysis. The specific NLRP3 inhibitor MCC950, caspase-1 inhibitor Ac-YVAD-cmk, and NF-κB inhibitor JSH23 were utilized to delineate the

SUBMITTER: Lai Y 

PROVIDER: S-EPMC11668076 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature